BARDA DRIVe EZ-BAA-22-100-SOL-00003

SOL #: BARDADRIVeEZBAA22100SOL00003Solicitation

Overview

Buyer

Health And Human Services
Office Of Assistant Secretary For Preparedness And Response
BARDA - ASPR / DAAPPO / BARDA DCMA
WASHINGTON, DC, 20515, United States

Place of Performance

Place of performance not available

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714)

PSC

Health R&D Services; Health Care Services; Experimental Development (AN13)

Set Aside

No set aside specified

Timeline

1
Posted
Oct 18, 2022
2
Submission Deadline
Oct 18, 2027, 7:00 PM

Qualification Details

Fit reasons
  • NAICS alignment with historical contract wins in similar service areas.
  • Scope strongly matches core technical capabilities and delivery model.
Risks
  • Past performance thresholds may require one additional teaming partner.
  • Potential clarification needed on staffing minimums before bid/no-bid.
Next steps

Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.

Quick Summary

The Department of Health and Human Services (HHS), through BARDA - ASPR / DAAPPO / BARDA DCMA, has reissued the BARDA DRIVe EZ-BAA, now designated EZ-BAA-22-100-SOL-00003. This Broad Agency Announcement (BAA) seeks innovative solutions in Health R&D Services and Experimental Development. Responses are due by October 18, 2027.

Scope of Work

This announcement supersedes and replaces prior iterations of the BARDA DRIVe EZ-BAA. It serves as a continuous call for proposals related to the DRIVe program's mission, which focuses on accelerating the development and availability of medical countermeasures and innovative health solutions. Specifics are detailed in the attached announcement and any applicable amendments.

Contract & Timeline

  • Type: Solicitation (Broad Agency Announcement - BAA)
  • Set-Aside: None Specified
  • Response Due: October 18, 2027, at 7:00 PM ET
  • Published: October 18, 2022

Evaluation

Proposals will be evaluated based on their scientific and technical merit, relevance to BARDA DRIVe's mission, and potential for advancing health R&D and experimental development.

Additional Notes

Interested parties are encouraged to reference the attached announcement and visit the official DRIVe website at https://drive.hhs.gov/ for comprehensive details and submission guidelines.

People

Points of Contact

Aarati SingalPRIMARY
Lara EmmonsSECONDARY

Files

Files

No files attached to this opportunity

Versions

Version 1Viewing
Solicitation
Posted: Oct 18, 2022
BARDA DRIVe EZ-BAA-22-100-SOL-00003 | GovScope